Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies

ClinicalTrials.gov ID: NCT05023486

Public ClinicalTrials.gov record NCT05023486. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 3:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Multicenter, open-label study in patients with advanced or metastatic solid tumor malignancies to evaluate the safety, tolerability, and preliminary anti-tumor efficacy, PK, and pharmacodynamics of continuously dosed NP-G2-044 monotherapy and NP-G2-044 in combination with anti-PD-1 therapy.

Study identification

NCT ID
NCT05023486
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Novita Pharmaceuticals, Inc.
Industry
Enrollment
121 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 7, 2021 (Actual)
Primary completion
Jun 30, 2026 (Actual)
Completion
Jun 30, 2026 (Actual)
Last update posted
Oct 9, 2026

2021 – 2026

United States locations

U.S. sites
18
U.S. states
13
U.S. cities
18
Facility City State ZIP Site status
Honor Health Research Institute Scottsdale Arizona 85258 —
University of Arizona - Cancer Center Tucson Arizona 85719 —
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
City of Hope Duarte California 91010 —
City of Hope Irvine Lennar Irvine California 92618 —
Hoag Memorial Hospital Presbyterian - Gynecologic Oncology Associates Newport Beach California 92663 —
Nuvance Health Norwalk Connecticut 06856 —
University of Florida (UF) - Shands Cancer Center Gainesville Florida 32610 —
Indiana University (IU) Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 —
University of Kansas Cancer Center Fairway Kansas 66205 —
Henry Ford Health System Detroit Michigan 48202 —
Atlantic Health System - Morristown Medical Center Morristown New Jersey 07962 —
University of Cincinnati (UC) - Cancer Institute Cincinnati Ohio 45219 —
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
University of Texas Southwestern Dallas Texas 75390 —
Virginia Cancer Specialists Fairfax Virginia 22031 —
Virginia Commonwealth University - Massey Cancer Center Richmond Virginia 23298 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05023486, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 9, 2026 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05023486 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →